Statistics Editor – Slobodan Jankovic MD, PhD
Slobodan M. Jankovic MD, DSc, MSc, Primarius, graduated at Medical Faculty, University of Belgrade in 1986, later becoming general surgery specialist and clinical pharmacology subspecialist. He works as Professor of Pharmacology, Toxicology and Clinical Pharmacy, and Head of Clinical Pharmacology Department, Clinical Center Kragujevac, Serbia. He is experienced in statistics, and modelling in pharmacoeconomics and pharmacokinetics.
Statistics Editor – Refet Gojak MD, PhD
Refet Gojak MD, PhD, specializes in infectious diseases, with a particular focus on Hepatitis C, Hepatitis B and Human Immunodeficiency Virus infections. He is a professor at the Faculty of Medicine of the University of Sarajevo, with extensive experience in scientific research and statistical data analysis.
Assistant Editor – Aida Pidro Gadzo MD, MSc
Aida Pidro Gadzo MD, MSc, is an ophthalmologist interested in cataract and oculoplastic surgery. Her journey in medicine is complemented by a master’s degree in Healthcare Quality Management, enriching her clinical practice with a profound understanding of healthcare administration and quality improvement initiatives. She is currently in her final stages of completing her doctoral studies.
Assistant Editor – Hana Sikira MD
Hana Sikira MD, graduated in 2017 from the Faculty of Medicine of the University of Sarajevo. She is currently in her fifth year of specialization in psychiatry and is employed at the Psychiatric Hospital of Sarajevo Canton. She has four years of experience as a research associate on international mental health projects.
Assistant Editor – Emir Sokolovic MD
Emir Sokolovic MD is a medical oncology resident at the Clinic of Oncology, Clinical Center University of Sarajevo. Emir has authored several publications in esteemed journals, covering a wide range of oncology topics, including breast cancer, melanoma, and gastrointestinal malignancies. His current research interests include the role of the microbiome in oncology and the use of artificial intelligence in analyzing real-world data on cancer treatment efficacy and toxicity.